Annals of Oncology · 2021 · 820 citations · 72 references
MedicineHematologyOncologyHematologic OncologyImmunotherapyMedical OncologyBone Marrow EvaluationHematologic MalignanciesHematologic Malignancy TherapyHematopoietic NeoplasmsMinimal Residual DiseaseMultiple MyelomaMultiple Myeloma TherapyMultiple Myeloma TreatmentMyeloid NeoplasmsRefractory Multiple MyelomaRelapsed Multiple Myeloma
72
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje, Jesús G. Berdeja, Yi Lin et al. · New England Journal of Medicine · 2019 · 1.7K citations · Full text
Medicine, Immunology, Oncology +17
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Antonio Palumbo, Asher Chanan‐Khan, Katja Weisel et al. · New England Journal of Medicine · 2016 · 1.5K citations · Full text
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
Meletios Α. Dimopoulos, Albert Oriol, Hareth Nahi et al. · New England Journal of Medicine · 2016 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +16